PepGen遭遇部分临床暂停,分析师归咎于“FDA人手不足”。
PepGen hit with partial clinical hold, analysts blame 'understaffed FDA'
生物技术与制药领域的最新动态
PepGen hit with partial clinical hold, analysts blame 'understaffed FDA'
Guardant hits the road with colon cancer blood test
Lonza to Establish GCC in Hyderabad to Strengthen Telangana’s Life Sciences Ecosystem? - Analytics India Magazine
Swiss pharma group Lonza to set up new GCC in Hyderabad - BusinessLine
Global life sciences hub: Lonza picks Hyderabad for new Global Capability Centre - NewsMeter
10x genomics CEO Saxonov sells $367,096 in shares - Investing.com
Cresset Asset Management LLC Increases Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
ARK Investment Management Boosts Stake in Illumina - National Today
ARK Investment Management LLC Has $139.41 Million Position in Illumina, Inc. $ILMN - MarketBeat
10x Genomics $TXG Shares Sold by ARK Investment Management LLC - MarketBeat
Roche, stakeholders urge Africa to treat health as economic investment - Realnews Magazine
Thermo Fisher expands immunodiagnostics operations with new distribution and labeling centre in Uppsala - BioSpectrum Asia
Thermo Fisher adds DXR3 SmartRaman+ for non-destructive, at-line Raman QC - R&D World
High school class spends a day at Agilent Technologies - Coastal View News
Octane Medical Group Signs Agreement to Acquire Lonza's Personalized Medicine Business - TMX Newsfile
Waters Corporation Stock Review 2026: Growth and Profitability Concerns - News and Statistics - IndexBox
Thermo Fisher introduces chromogenic culture media for faster identification of Candida infections - R&D World
10x Genomics (TXG) CEO sells shares and makes stock gift - Stock Titan
Roche pumps $480M into South Korea biopharma industry to establish global trial 'ecosystem'
Pfizer's oncology R&D strategy: Jeff Legos on speed, breadth and novel combinations